Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Atypical Hemolytic Uremic Syndrome × ravulizumab × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Myasthenia Gravis 6 Neuromyelitis Optica 2 Recurrence 1 Optic Neuritis 1 Myelitis, Transverse 1 Hemoglobinuria, Paroxysmal 1 Demyelinating Diseases 1 Atypical Hemolytic Uremic Syndrome 1 Adrenal Insufficiency 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06312644 2026-04-16

Study of Ultomiris® (Ravulizumab) Safety in Pregnancy

Alexion Pharmaceuticals, Inc.

Classical hematology

Hemoglobinuria, Paroxysmal, Myasthenia Gravis, Neuromyelitis Optica, Atypical Hemolytic Uremic Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡